177 related articles for article (PubMed ID: 29337599)
1. Pearson syndrome.
Farruggia P; Di Marco F; Dufour C
Expert Rev Hematol; 2018 Mar; 11(3):239-246. PubMed ID: 29337599
[TBL] [Abstract][Full Text] [Related]
2. An infant with Pearson syndrome: a rare cause of congenital sideroblastic anemia and bone marrow failure.
Falcon CP; Howard TH
Blood; 2017 May; 129(19):2710. PubMed ID: 28495927
[No Abstract] [Full Text] [Related]
3. Sideroblastic anemia associated with multisystem mitochondrial disorders.
Tesarova M; Vondrackova A; Stufkova H; Veprekova L; Stranecky V; Berankova K; Hansikova H; Magner M; Galoova N; Honzik T; Vodickova E; Stary J; Zeman J
Pediatr Blood Cancer; 2019 Apr; 66(4):e27591. PubMed ID: 30588737
[TBL] [Abstract][Full Text] [Related]
4. Induced pluripotent stem cells with a mitochondrial DNA deletion.
Cherry AB; Gagne KE; McLoughlin EM; Baccei A; Gorman B; Hartung O; Miller JD; Zhang J; Zon RL; Ince TA; Neufeld EJ; Lerou PH; Fleming MD; Daley GQ; Agarwal S
Stem Cells; 2013 Jul; 31(7):1287-97. PubMed ID: 23400930
[TBL] [Abstract][Full Text] [Related]
5. Pearson Syndrome, A Medical Diagnosis Difficult to Sustain Without Genetic Testing.
Sur L; Floca E; Samasca G; Lupan I; Aldea C; Sur G
Clin Lab; 2018 Mar; 64(3):375-377. PubMed ID: 29739102
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial DNA with a large-scale deletion causes two distinct mitochondrial disease phenotypes in mice.
Katada S; Mito T; Ogasawara E; Hayashi J; Nakada K
G3 (Bethesda); 2013 Sep; 3(9):1545-52. PubMed ID: 23853091
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow features in Pearson syndrome with neonatal onset: A case report and review of the literature.
Tadiotto E; Maines E; Degani D; Balter R; Bordugo A; Cesaro S
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286581
[TBL] [Abstract][Full Text] [Related]
8. Pearson syndrome in a Diamond-Blackfan anemia cohort.
Alter BP
Blood; 2014 Jul; 124(3):312-3. PubMed ID: 25035146
[TBL] [Abstract][Full Text] [Related]
9. Broad Phenotypic Heterogeneity and Multisystem Involvement in Single mtDNA Deletion-associated Pearson Syndrome.
Finsterer J; Scorza FA; Scorza CA
Med Arch; 2018 Jun; 72(3):234-236. PubMed ID: 30061775
[No Abstract] [Full Text] [Related]
10. Clinical manifestations and management of four children with Pearson syndrome.
Tumino M; Meli C; Farruggia P; La Spina M; Faraci M; Castana C; Di Raimondo V; Alfano M; Pittalà A; Lo Nigro L; Russo G; Di Cataldo A
Am J Med Genet A; 2011 Dec; 155A(12):3063-6. PubMed ID: 22012855
[TBL] [Abstract][Full Text] [Related]
11. Novel 5.712 kb mitochondrial DNA deletion in a patient with Pearson syndrome: a case report.
Park J; Ryu H; Jang W; Chae H; Kim M; Kim Y; Kim J; Lee JW; Chung NG; Cho B; Suh BK
Mol Med Rep; 2015 May; 11(5):3741-5. PubMed ID: 25543536
[TBL] [Abstract][Full Text] [Related]
12. The fate of medium-chain fatty acids in very long-chain acyl‑CoA dehydrogenase deficiency (VLCADD): A matter of sex?
Wehbe Z; Alatibi K; Jellusova J; Spiekerkoetter U; Tucci S
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1591-1605. PubMed ID: 31394165
[TBL] [Abstract][Full Text] [Related]
13. Broadening the phenotypic spectrum of Pearson syndrome: Five new cases and a review of the literature.
Wild KT; Goldstein AC; Muraresku C; Ganetzky RD
Am J Med Genet A; 2020 Feb; 182(2):365-373. PubMed ID: 31825167
[TBL] [Abstract][Full Text] [Related]
14. Pearson marrow pancreas syndrome in patients suspected to have Diamond-Blackfan anemia.
Gagne KE; Ghazvinian R; Yuan D; Zon RL; Storm K; Mazur-Popinska M; Andolina L; Bubala H; Golebiowska S; Higman MA; Kalwak K; Kurre P; Matysiak M; Niewiadomska E; Pels S; Petruzzi MJ; Pobudejska-Pieniazek A; Szczepanski T; Fleming MD; Gazda HT; Agarwal S
Blood; 2014 Jul; 124(3):437-40. PubMed ID: 24735966
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations and enzymatic activities of mitochondrial respiratory chain complexes in Pearson marrow-pancreas syndrome with 3-methylglutaconic aciduria: a case report and literature review.
Sato T; Muroya K; Hanakawa J; Iwano R; Asakura Y; Tanaka Y; Murayama K; Ohtake A; Hasegawa T; Adachi M
Eur J Pediatr; 2015 Dec; 174(12):1593-602. PubMed ID: 26074369
[TBL] [Abstract][Full Text] [Related]
16. A novel mitochondrial DNA deletion in a patient with Pearson syndrome and neonatal diabetes mellitus provides insight into disease etiology, severity and progression.
Chen XY; Zhao SY; Wang Y; Wang D; Dong CH; Yang Y; Wang ZH; Wu YM
Mitochondrial DNA A DNA Mapp Seq Anal; 2016 Jul; 27(4):2492-5. PubMed ID: 26016877
[TBL] [Abstract][Full Text] [Related]
17. Nutrition management guideline for very-long chain acyl-CoA dehydrogenase deficiency (VLCAD): An evidence- and consensus-based approach.
Van Calcar SC; Sowa M; Rohr F; Beazer J; Setlock T; Weihe TU; Pendyal S; Wallace LS; Hansen JG; Stembridge A; Splett P; Singh RH
Mol Genet Metab; 2020; 131(1-2):23-37. PubMed ID: 33093005
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial single-stranded DNA binding protein novel de novo SSBP1 mutation in a child with single large-scale mtDNA deletion (SLSMD) clinically manifesting as Pearson, Kearns-Sayre, and Leigh syndromes.
Gustafson MA; McCormick EM; Perera L; Longley MJ; Bai R; Kong J; Dulik M; Shen L; Goldstein AC; McCormack SE; Laskin BL; Leroy BP; Ortiz-Gonzalez XR; Ellington MG; Copeland WC; Falk MJ
PLoS One; 2019; 14(9):e0221829. PubMed ID: 31479473
[TBL] [Abstract][Full Text] [Related]
19. Pearson syndrome: unique endocrine manifestations including neonatal diabetes and adrenal insufficiency.
Williams TB; Daniels M; Puthenveetil G; Chang R; Wang RY; Abdenur JE
Mol Genet Metab; 2012 May; 106(1):104-7. PubMed ID: 22424738
[TBL] [Abstract][Full Text] [Related]
20. Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.
Tucci S
J Inherit Metab Dis; 2017 May; 40(3):317-323. PubMed ID: 28247148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
